EDITAS MEDICINE, INC. Marketable Securities
EDITAS MEDICINE, INC. (EDIT) had Marketable Securities of $598.72 million as of 2020-06-30, per its 10-Q filed 2020-08-07.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2021-02-26
- 2020-06-30: Marketable Securities $598.72M.
- 2020-03-31: Marketable Securities $414.99M.
- 2019-12-31: Marketable Securities $460.81M.
- 2019-09-30: Marketable Securities $336.28M.
| Period end | Marketable Securities |
|---|---|
| 2020-06-30 | $598.72M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $414.99M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $460.81M 10-K · filed 2021-02-26 |
| 2019-09-30 | $336.28M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $321.60M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $345.51M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $372.38M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |